DK1246611T3 - Formuleringer af aktive bestanddele i form af en fast dispersion - Google Patents

Formuleringer af aktive bestanddele i form af en fast dispersion

Info

Publication number
DK1246611T3
DK1246611T3 DK01915129T DK01915129T DK1246611T3 DK 1246611 T3 DK1246611 T3 DK 1246611T3 DK 01915129 T DK01915129 T DK 01915129T DK 01915129 T DK01915129 T DK 01915129T DK 1246611 T3 DK1246611 T3 DK 1246611T3
Authority
DK
Denmark
Prior art keywords
solid dispersion
formulations
active ingredients
solid
carrier
Prior art date
Application number
DK01915129T
Other languages
English (en)
Inventor
Bernhard Lippold
Nora Anne Urbanetz
Original Assignee
Abbott Gmbh & Co Kg
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=7627157&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK1246611(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Abbott Gmbh & Co Kg filed Critical Abbott Gmbh & Co Kg
Application granted granted Critical
Publication of DK1246611T3 publication Critical patent/DK1246611T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
    • A61K9/146—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic macromolecular compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4422—1,4-Dihydropyridines, e.g. nifedipine, nicardipine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1635—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1641—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, poloxamers

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Compositions Of Macromolecular Compounds (AREA)
DK01915129T 2000-01-11 2001-01-10 Formuleringer af aktive bestanddele i form af en fast dispersion DK1246611T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE10000792A DE10000792A1 (de) 2000-01-11 2000-01-11 Formulierungen von Wirkstoffen in Form einer festen Dispersion
PCT/EP2001/000224 WO2001051025A2 (de) 2000-01-11 2001-01-10 Formulierungen von wirkstoffen in form einer festen dispersion

Publications (1)

Publication Number Publication Date
DK1246611T3 true DK1246611T3 (da) 2008-01-28

Family

ID=7627157

Family Applications (1)

Application Number Title Priority Date Filing Date
DK01915129T DK1246611T3 (da) 2000-01-11 2001-01-10 Formuleringer af aktive bestanddele i form af en fast dispersion

Country Status (9)

Country Link
US (1) US8021688B2 (da)
EP (1) EP1246611B1 (da)
AT (1) ATE373470T1 (da)
AU (1) AU2001242328A1 (da)
CA (1) CA2396722C (da)
DE (2) DE10000792A1 (da)
DK (1) DK1246611T3 (da)
ES (1) ES2293982T3 (da)
WO (1) WO2001051025A2 (da)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10026698A1 (de) 2000-05-30 2001-12-06 Basf Ag Selbstemulgierende Wirkstoffformulierung und Verwendung dieser Formulierung
US8377952B2 (en) 2003-08-28 2013-02-19 Abbott Laboratories Solid pharmaceutical dosage formulation
US8025899B2 (en) 2003-08-28 2011-09-27 Abbott Laboratories Solid pharmaceutical dosage form
FR2880274B1 (fr) * 2004-12-30 2007-04-13 Pierre Fabre Medicament Sa Dispersion solide stable d'un derive d'alcaloides de vinca et son procede de fabrication
RS52697B (en) * 2004-12-30 2013-08-30 Pierre Fabre Medicament STABLE SOLID DISPERSION OF WIND ALKALOID DERIVATIVES AND PROCEDURE FOR ITS PRODUCTION
US9539331B2 (en) 2011-12-21 2017-01-10 Bayer Intellectual Property Gmbh Preparations containing amorphous emodepside
CN103271902B (zh) * 2013-05-07 2015-11-11 西安交通大学 一种难溶性药物固体分散体及其制备方法
CN109481411B (zh) * 2017-09-13 2021-02-02 亚宝药业集团股份有限公司 一种尼莫地平的热熔挤出固体分散体及其片剂制备方法
CN114699373B (zh) * 2022-03-30 2023-03-17 山东新时代药业有限公司 一种甲氧氯普胺固体分散体及其制备方法

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4291015A (en) 1979-08-14 1981-09-22 Key Pharmaceuticals, Inc. Polymeric diffusion matrix containing a vasodilator
US4292104A (en) * 1979-09-13 1981-09-29 Corning Glass Works Decalcomania manufacture
US4321263A (en) * 1980-09-30 1982-03-23 Rowell Laboratories, Inc. Psyllium compositions
US4764378A (en) * 1986-02-10 1988-08-16 Zetachron, Inc. Buccal drug dosage form
US5368864A (en) * 1988-11-25 1994-11-29 Henning Berlin Gmbh Chemie- Und Pharmawerk Formulation of oxypurinol and/or its alkali and alkaline earth salts
DE3839825A1 (de) * 1988-11-25 1990-06-13 Henning Berlin Gmbh Feststoffdispersionen enthaltend oxipurinol und/oder seine alkali- oder erdalkalisalze
US5080471A (en) * 1990-04-06 1992-01-14 Eic Laboratories, Inc. Electrochromic material and electro-optical device using same
JP2696438B2 (ja) * 1991-04-22 1998-01-14 富士写真フイルム株式会社 熱現像感光材料
DK0617612T3 (da) * 1991-12-18 1998-04-14 Warner Lambert Co Fremgangsmåde til fremstilling af en fast dispersion
US5294615A (en) * 1993-04-29 1994-03-15 Abbott Laboratories Terazosin polymorph and pharmaceutical composition
US5599583A (en) * 1994-05-27 1997-02-04 Micro Flo Company Encapsulation with water soluble polymer
KR100239799B1 (ko) * 1995-01-21 2000-02-01 손경식 경구투여용 사이클로스포린 에이 고체미셀분산체, 이의 제조 방법 및 고형제제
US5637319A (en) * 1995-03-01 1997-06-10 Takada; Kanji Controlled-release preparations
US6391338B1 (en) * 1995-09-07 2002-05-21 Biovail Technologies Ltd. System for rendering substantially non-dissoluble bio-affecting agents bio-available
DE19701949A1 (de) * 1997-01-13 1998-07-16 Jenapharm Gmbh Transdermales therapeutisches System
US5955475A (en) * 1997-06-30 1999-09-21 Endo Pharmaceuticals Inc. Process for manufacturing paroxetine solid dispersions
US6086915A (en) * 1998-04-01 2000-07-11 Bioresponse L.L.C. Compositions and methods of adjusting steroid hormone metabolism through phytochemicals
US6168805B1 (en) 1998-05-07 2001-01-02 Endo Pharmaceuticals, Inc. Aqueous process for manufacturing paroxetine solid dispersions

Also Published As

Publication number Publication date
DE50113030D1 (de) 2007-10-31
WO2001051025A3 (de) 2002-04-18
ES2293982T3 (es) 2008-04-01
EP1246611B1 (de) 2007-09-19
DE10000792A1 (de) 2001-07-19
AU2001242328A1 (en) 2001-07-24
ATE373470T1 (de) 2007-10-15
US20030109639A1 (en) 2003-06-12
CA2396722C (en) 2008-08-19
EP1246611A2 (de) 2002-10-09
WO2001051025A2 (de) 2001-07-19
CA2396722A1 (en) 2001-07-19
US8021688B2 (en) 2011-09-20

Similar Documents

Publication Publication Date Title
PT1073470E (pt) Composicoes farmaceuticas contendo compostos com actividade capaz de melhorar a absorcao de ingredientes activos
KR910015298A (ko) 오메프라졸 직장투여조성물
EA200400067A1 (ru) Конъюгаты гксф
CA2420874A1 (en) Active ingredient combinations with insecticidal and acaricidal properties
RS54275B1 (sr) Vodeni 2,6-diizopropilfenol farmaceutski sastavi
CY1106908T1 (el) Φαρμακευτικη τυποποιηση απο του στοματος που περιεχει ενα αδρομερες συμπολυμερες
RS50193B (sr) Stabilni kompleksi slabo rastvornih jedinjenja
DE69914787D1 (de) Flüssige zusammensetzungen mit kontrollierter freigabe mit niedrigem initialfreisetzungsstoss des wirkstoffs
DE60104206D1 (de) Halbfeste arzneizubereitung enthaltend isotretinoin
BR0113608A (pt) Composição cosmética clara em emulsão antiperspirante e/ou desodorante
DE69307977D1 (de) Stabilisierte Derivate von Vitamin D2 und D3 enthaltende pharmazeutische Zusammensetzungen
DK1246611T3 (da) Formuleringer af aktive bestanddele i form af en fast dispersion
MX9305535A (es) Composiciones y concentrados germicidas a base de yodo-detergente, acuosos y estables.
DE602004019546D1 (de) Heterofunktionelle copolymere von glycerol und polyethylenglykol, ihre konjugate und zusammensetzungen
WO2002047657A3 (en) Composition containing heteropolymers and oil-soluble polymers
DK1189971T3 (da) Funktionelle poly-alpha-aminosyrederivater der er egnede til modificering af biologisk aktive materialer, samt anvendelse deraf
MXPA04003199A (es) Composicion que contiene particulas para estilizar el cabello.
BR0207646A (pt) Composição estabilizadora para polìmeros halogenados, uso da mesma e polìmeros que compreendem tais composições
DE50101994D1 (en) Antistatische polyoxymethylenformmassen
HUP0000818A2 (hu) Vizes készítmények és alkalmazásuk
CO4940362A1 (es) Composiciones para esterilizar el pelo que poseen una mejor capacidad de ser eliminadas del pelo, que comprenden un co- polimero que contiene silicona y un disolvente para dicho copolimero
ATE114455T1 (de) Zahnreinigende zusammensetzungen.
ATE307579T1 (de) Pektin und ascorbinsäure enthaltende zusammensetzungen
RS50074B (sr) Farmaceutski preparat koji sadrži paracetamol i drotaverin
DE60108509D1 (de) Härtbare zusammensetzungen,die polysäure(n) und polyol(e) enthalten